Surgical treatment of liver metastases from breast cancer
INTRODUCTION: A small number of patients with breast cancer develop liver metastases (LM) as the sole site of regional dissemination. In these patients, surgical resection seems to be the best therapeutic option. We present our experience of LM from breast cancer and discuss the indications for resection.
MATERIAL AND METHODS: Between July 2003 and March 2005, we performed five hepatectomies for LM from breast cancer. The mean age was 51 years (range: 38-66). Patients received diverse combinations of chemotherapy, hormone therapy and radiotherapy after mastectomy. The disease-free interval between mastectomy and diagnosis of LM was 61 months (range: 36-80). The number of LM was 1.83 (range: 1-6) with a median of one LM. The mean size was 4.1 cm (range: 1.5-6).
RESULTS: Surgery consisted of segmentectomy (three patients), bisegmentectomy (one patient), right hepatectomy associated with isolated metasectomies of the left lobe and hilar lymphadenectomy (one patient). Operative mortality was 0%. Morbidity was 20% (one patient). The mean length of hospital stay was 8 days. The mean length of follow-up was 11.4 months (range: 3-21). The mean survival was 11.4 months (range: 3-21). Disease-free survival was 9.6 months (range: 3-21). Two patients have had recurrence (one local and one regional).
CONCLUSIONS: Given its characteristics, LM from breast cancer is an infrequent indication for liver resection and should be performed whenever technically feasible, whenever R0 resection can be achieved, and when there is low operative risk. Postoperative survival is better with resection than with any other therapeutic modality, even though the period of disease-free survival is short.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2005 |
---|---|
Erschienen: |
2005 |
Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
---|---|
Enthalten in: |
Cirugia espanola - 78(2005), 5 vom: 19. Nov., Seite 318-22 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Tratamiento quirúrgico de las metástasis hepáticas de cáncer de mama |
---|
Beteiligte Personen: |
Ramia, José Manuel [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.04.2006 Date Revised 09.11.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM160181771 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM160181771 | ||
003 | DE-627 | ||
005 | 20231223085609.0 | ||
007 | tu | ||
008 | 231223s2005 xx ||||| 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n0534.xml |
035 | |a (DE-627)NLM160181771 | ||
035 | |a (NLM)16420849 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Ramia, José Manuel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Surgical treatment of liver metastases from breast cancer |
246 | 3 | 3 | |a Tratamiento quirúrgico de las metástasis hepáticas de cáncer de mama |
264 | 1 | |c 2005 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 04.04.2006 | ||
500 | |a Date Revised 09.11.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: A small number of patients with breast cancer develop liver metastases (LM) as the sole site of regional dissemination. In these patients, surgical resection seems to be the best therapeutic option. We present our experience of LM from breast cancer and discuss the indications for resection | ||
520 | |a MATERIAL AND METHODS: Between July 2003 and March 2005, we performed five hepatectomies for LM from breast cancer. The mean age was 51 years (range: 38-66). Patients received diverse combinations of chemotherapy, hormone therapy and radiotherapy after mastectomy. The disease-free interval between mastectomy and diagnosis of LM was 61 months (range: 36-80). The number of LM was 1.83 (range: 1-6) with a median of one LM. The mean size was 4.1 cm (range: 1.5-6) | ||
520 | |a RESULTS: Surgery consisted of segmentectomy (three patients), bisegmentectomy (one patient), right hepatectomy associated with isolated metasectomies of the left lobe and hilar lymphadenectomy (one patient). Operative mortality was 0%. Morbidity was 20% (one patient). The mean length of hospital stay was 8 days. The mean length of follow-up was 11.4 months (range: 3-21). The mean survival was 11.4 months (range: 3-21). Disease-free survival was 9.6 months (range: 3-21). Two patients have had recurrence (one local and one regional) | ||
520 | |a CONCLUSIONS: Given its characteristics, LM from breast cancer is an infrequent indication for liver resection and should be performed whenever technically feasible, whenever R0 resection can be achieved, and when there is low operative risk. Postoperative survival is better with resection than with any other therapeutic modality, even though the period of disease-free survival is short | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Villar, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Villegas, Trinidad |e verfasserin |4 aut | |
700 | 1 | |a Muffak, Karim |e verfasserin |4 aut | |
700 | 1 | |a Garrote, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Ferrón, José Antonio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cirugia espanola |d 1976 |g 78(2005), 5 vom: 19. Nov., Seite 318-22 |w (DE-627)NLM012342238 |x 1578-147X |7 nnns |
773 | 1 | 8 | |g volume:78 |g year:2005 |g number:5 |g day:19 |g month:11 |g pages:318-22 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 78 |j 2005 |e 5 |b 19 |c 11 |h 318-22 |